Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

As of July 13, 2022, approximately 53.7 million people in the United Kingdom had received the first dose of the COVID-19 vaccination. The UK was the first country in the world to approve the use of the Pfizer/BioNTech vaccine, and began inoculations on December 8, 2020. Nearly all the vaccines currently being used in the UK require two doses for full efficacy to occur, and according to the latest data around 50.3 million people had received their second dose of the immunization. Furthermore, 40.1 million booster vaccinations had been administered.

The total number of cases in the UK can be found here. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

This statistical report, co-authored with the UK Health Security Agency (UKSHA), reports childhood vaccination coverage statistics for England in 2023-24. Data relates to the routine vaccinations offered to all children up to the age of 5 years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through UKHSA's ImmForm system.

According to a survey of parents of young children in England in 2022, almost ** percent of respondents reported the roll out of the COVID-19 vaccination had made them feel that vaccines have never been more important in preventing the spread of infections and viruses. While around ** percent of respondents said that COVID-19 had not changed their perceptions of vaccines either positively or negatively, ** percent said the COVID-19 vaccine roll-out had made them more wary about vaccinations.

Coronavirus (COVID-19) vaccination rates among adults who live in England, including estimates by socio-demographic characteristic and Standard Occupational Classification (SOC) 2020

Between January 1, 2021 and May 31, 2022, there were approximately 30.6 thousand deaths involving COVID-19 among 80 to 89 year olds in England, with over 14 thousand deaths occurring among unvaccinated people in this age group. Across all the age groups in the provided time interval, deaths involving COVID-19 among the unvaccinated population was around double the amount of people who received at least two doses of a vaccine. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the Code of Practice for Statistics that all producers of official statistics should adhere to.

Provisional monthly uptake data for seasonal influenza and COVID-19 vaccines for frontline HCWs working in trusts, Independent Sector Healthcare Providers (ISHCPs), and GP practices in England.

Data is presented at national, NHS regional and individual trust levels.

View the pre-release access list for these reports.

Includes: Patient demographics, Source Organisation, vaccination details and vaccine batch events. Its scope covers: Anyone vaccinated within England Anyone vaccinated in a Devoted Administration where this information is subsequently passed to England.

Settings include: hospital hubs - NHS providers vaccinating on site local vaccine services – community or primary care led services which could include primary care facilities, retail, community facilities, temporary structures or roving teams vaccination centres – large sites such as sports and conference venues set up for high volumes of people

Timescales for dissemination can be found under 'Our Service Levels' at the following link: https://digital.nhs.uk/services/data-access-request-service-dars/data-access-request-service-dars-process

Indicators from the Vaccine Opinions Study to understand changes in uptake and attitudes towards the coronavirus (COVID-19) vaccines, amongst adults in England who previously reported they had declined the vaccine or were unlikely or unsure about having the vaccine if offered.

This statistical report, co-authored with Public Health England (PHE), reports childhood vaccination coverage statistics for England in 2018-19. Data relates to the routine vaccinations offered to all children up to the age of five years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through PHE's ImmForm system.

According to a survey carried out in England, ** percent of parents in England overall reported to have come across information that made them realize the importance of childhood vaccinations. Of these, ** percent said they came across information about a specific vaccine.

This statistical report, co-authored with Public Health England (PHE), reports childhood vaccination coverage statistics for England in 2019-20. Data relates to the routine vaccinations offered to all children up to the age of five years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through PHE's ImmForm system.

This statistic displays the proportion of children who received the pneumococcal conjugate vaccine (PCV) (primary and booster) in England in 2023/24, by region. In this period, 96.9 percent of children in the North East of England had received the PCV primary immunizations by their first birthday.

Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, overall and by age group, using anonymised linked data from Census 2021. Experimental Statistics.

Outcome definitions

For this analysis, we define a death as involving COVID-19 if either of the ICD-10 codes U07.1 (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified) is mentioned on the death certificate. Information on cause of death coding is available in the User Guide to Mortality Statistics. We use date of occurrance rather than date of registration to give the date of the death.

We define COVID-109 hospitalisation as an inpatient episode in Hospital Episode Statistics where the primary diagnosis was COVID-19, identified by the ICD-19 codes (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified). Where an individual had experienced more than one COVID-19 hospitalisation, the earliest that occurred within the study period was used. We define the date of COVID-19 hospitalisation as the start of the hospital episode.

ICD-10 code

U07.1 :

COVID-19, virus identified

U07.2:

COVID-19, virus not identified

Vaccination status is defined by the dose and the time since the last dose received

Unvaccinated:

no vaccination to less than 21 days post first dose

First dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post first dose or less than 21 days post second dose

First dose 3+ months:

more than or equal to 91 days post first dose to less than 21 days post second dose

Second dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post second dose or less than 21 days post third dose

Second dose 3-6 months:

more than or equal to 91 days post second dose to earliest of less than 182 days post second dose or less than 21 days post third dose

Second dose 6+ months:

more than or equal to 182 days post second dose to less than 21 days post third dose

Third dose 21 days to 3 months:

more than or equal to 21 days post third dose to less than 91 days post third dose

Third dose 3+ months:

more than or equal to 91 days post third dose

Model adjustments

Three sets of model adjustments were used

Age adjusted:

age (as a natural spline)

Age, socio-demographics adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status)

Fully adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status), plus health-related characteristics (disability, self-reported health, care home residency, number of QCovid comorbidities (grouped), BMI category, frailty flag and hospitalisation within the last 21 days.

Age

Age in years is defined on the Census day 2021 (21 March 2021). Age is included in the model as a natural spline with boundary knots at the 10th and 90th centiles and internal knots at the 25th, 50th and 75th centiles. The positions of the knots are calculated separately for the overall model and for each age group for the stratified model.

This dataset illustrates uptake inequalities of fourth doses of the coronavirus (COVID-19) vaccine using 2021 Census-derived demographic and socio-economic characteristics: age. sex, ethnicity, religion, socio-economic status and self-reported disability and health status.

Vaccination data are produced using linked data from Deaths registrations and Census 2021, National Immunisation Management Service, Hospital Episode Statistics and General Practise Extraction Service data for Pandemic Planning and Research.

Data may differ from weekly administrative vaccination data published by NHS England.

Estimates of vaccine sentiment with breakdowns by different population groups. Analysis based on the Opinions and Lifestyle Survey.

Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the Code of Practice for Statistics that all producers of official statistics should adhere to.

Provisional monthly data for the uptake of the seasonal influenza vaccine in GP-registered patients in England.

Data is presented by current NHS geographies and by local authority.

View the pre-release access list for these reports.

Flu vaccine uptake (%) in children aged 2 to 3 years old, who received the flu vaccination between 1st September to the end of February as recorded in the GP record. The February collection has been adopted for our end of season figures from 2017 to 2018. All previous data is the same definitions but until the end of January rather than February to consider data returning from outside the practice and later in practice vaccinations.RationaleInfluenza (also known as Flu) is a highly infectious viral illness spread by droplet infection. The flu vaccination is offered to people who are at greater risk of developing serious complications if they catch the flu. The seasonal influenza programme for England is set out in the Annual Flu Letter. Both the flu letter and the flu plan have the support of the Chief Medical Officer (CMO), Chief Pharmaceutical Officer (CPhO), and Director of Nursing.Vaccination coverage is the best indicator of the level of protection a population will have against vaccine-preventable communicable diseases. Immunisation is one of the most effective healthcare interventions available, and flu vaccines can prevent illness and hospital admissions among these groups of people. Increasing the uptake of the flu vaccine among these high-risk groups should also contribute to easing winter pressure on primary care services and hospital admissions. Coverage is closely related to levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise.The UK Health Security Agency (UKHSA) will continue to provide expert advice and monitoring of public health, including immunisation. NHS England now has responsibility for commissioning the flu programme, and GPs continue to play a key role. NHS England teams will ensure that robust plans are in place locally and that high vaccination uptake levels are reached in the clinical risk groups. For more information, see the Green Book chapter 19 on Influenza.The Annual flu letter sets out the national vaccine uptake ambitions each year. In 2021 to 2022, the national ambition was to achieve at least 70% vaccine uptake in those aged 2 to 3 years old. Prior to this, the national vaccine uptake ambition was 75% in line with WHO targets.Definition of numeratorNumerator is the number of vaccinations administered during the influenza season between 1st September and the end of February.Definition of denominatorDenominator is the GP registered population on the date of extraction including patients who have been offered the vaccine but refused it, as the uptake rate is measured against the overall eligible population. For more detailed information please see the user guide, available to view and download from https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptakeCaveatsThis collection has received approval from the Data Coordination Board (DCB).Data is final and represents a percentage of all GP practices in England responding to the final survey. Where a total for England is quoted (e.g., a sum of the number of patients registered and number vaccinated), this is taken from the GP practice sample and is therefore not an extrapolated figure.For definitions of clinical at-risk groups for those aged 6 months to under 65 years, see the annual flu letter published at Annual Flu Programme.The age under 65 clinical at-risk group data includes pregnant women with other risk factors but excludes otherwise 'healthy' pregnant women and carers.All figures are derived from data as extracted from records on GP systems or as submitted by GP practices, Area Teams, and CCGs.Data source: ImmForm website: registered patient GP practice data, Influenza Immunisation Vaccine Uptake Monitoring Programme, OHID.